Search results
Results from the WOW.Com Content Network
This article discusses the current approach to patient management. Chronic obstructive pulmonary disease (COPD) is a poorly reversible disease of the lungs that is one of the major causes of morbidity and mortality worldwide.
Chronic obstructive lung disease is a lung disease characterized by lung airflow limitation and can be from exposure to harmful substances. It is a common cause of death worldwide. To avoid the high morbidity and mortality associated with this condition, it must be diagnosed and treated promptly.
COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible.
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation is an open access, peer-reviewed medical/scientific journal dedicated to publishing original research, reviews, and communications related to COPD. Articles are published online as quickly as possible following peer review and editorial acceptance and then aggregated into ...
Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue.
INTRODUCTION. Chronic obstructive pulmonary disease (COPD) is a major global health problem due to its high prevalence (about 10% of the adult population), rising incidence (related in part to the aging of the population) and very significant associated personal, social, and economic costs (23a).
EQ-5D Based Utility Values for Adults with Chronic Obstructive Pulmonary Disease: A Systematic Review, Meta-Analysis, and Meta-Regression. Natasha Salant, Syed Mohiuddin, Yuanyuan Zhang, Lynda Ayiku, Kusal Lokuge, Paul Jacklin & Lesley Owen. Article: 2385358.
Researchers analyzed 7336 survey responses and created six research areas to reflect their suggestions: (1) family/social/community research, (2) well-being, (3) research on a cure for COPD, (4) new drugs and treatments, (5) policy concerns, and (6) natural therapies.
A pair of review articles examines our current understanding of the biology, diagnosis, and treatment of chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, with 3·23 million deaths reported in 2019. For a long time, COPD was seen as a disease of smokers—a terminal disease, diagnosed in older people, with few treatment options.